2020 Annual Meeting | C2 - Update on Medical Management of Stroke
07:00 AM - 08:00 AM | Speaker |
Acute Medical Management
Adam De Havenon, MD, FAAN, Claire Creutzfeldt, MD |
08:00 AM - 09:00 AM | Speaker |
Sub-acute Medical Management
Adam De Havenon, MD, FAAN, Amy K. Guzik, MD, FAAN |
Adam De Havenon, MD, FAAN | Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has stock in Certus. Dr. De Havenon has stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care. |
Claire Creutzfeldt, MD | The institution of Dr. Creutzfeldt has received research support from NINDS. The institution of Dr. Creutzfeldt has received research support from NINR. |
Amy K. Guzik, MD, FAAN | Dr. Guzik has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local law firms, available by request. |